Back

Prediction of CRT response using a novel CRT responder score in an Asian patient population

2 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Devices in heart failure: new findings Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Yusuke Kondo

Chiba University Graduate School of Medicine, Chiba (Japan)

7 More presentations in this session

Presentation thumbnail
Predictors of Right vEntricular Failure aftER LVAD implantation: PREFER LVAD study
Associate Professor M. Cameli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Elevated cancer biomarkers in patients with severe heart failure could be a potential predictor of mortality during LVAD support
Doctor A. Bielka (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Right ventricular failure following left ventricular assist device implantation.
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study
Doctor S. Hegde (Charlotte, US)
Abstract Slides Video
Presentation thumbnail
A meta-analysis of the efficacy and safety of exercise-based cardiac rehabilitation in patients with left ventricular assist devices.
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Devices in heart failure: new findings

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Myocardial single photon emission computed tomography imaging to identify non-responders to cardiac resynchronization therapy in patients with non-left bundle branch block
thumbnail
Congress Presentation
Risk stratification in patients with cardiac resynchronization therapy: a comparison of EAARN, AAACC, and AL-FINE risk score
thumbnail
Congress Presentation
Predictors of negative response to cardiac resynchronization therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources